There’s a new fight brewing between manufacturers of weight loss drugs and the compounding pharmacies ... Meanwhile, a similar fight over Novo Nordisk’s wildly popular drugs Ozempic and Wegovy looms.

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

About 154 million non-elderly Americans rely on employer-sponsored coverage, and the 26th annual survey of more than 2,100 ...

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Health-care costs are going up and and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Ozempic.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...